TIDMFDBK

RNS Number : 0123A

Feedback PLC

31 January 2022

Feedback plc

Notice of Results

London, 31 January 2022 : Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, will announce results for the half year ended 30 November 2021 on Thursday 10 February 2022.

Analyst Briefing, 9:30am, Thursday 10 February 2022

A briefing for Analysts will be held at 9:30am GMT on the day of the results.

Analysts interested in attending should contact Walbrook PR by emailing feedbackplc@walbrookpr.com or by calling 020 7933 8780.

Further information on Feedback and its products can be found on the Company's website: https://fbkmed.com/feedback-plc/reports-and-presentations/

-Ends-

Enquiries:

 
 Feedback plc                             +44 (0) 20 3997 7634 
  Tom Oakley, CEO                          IR@fbk.com 
  Anesh Patel, CFO 
 
 Panmure Gordon (UK) Limited (NOMAD 
  and Broker) 
  Emma Earl/Freddy Crossley (Corporate 
  Finance) 
  Rupert Dearden (Corporate Broking)      +44 (0)20 7886 2500 
 
 Walbrook PR Ltd                          Tel: 020 7933 8780 or feedbackplc@walbrookpr.com 
 Paul McManus/Nick Rome/Nicholas          07980 541 893 or 07748 325 236 
  Johnson                                  or 07884 664 686

About Feedback

Feedback plc is a specialist clinical communications business, with a mission to improve the efficiency and quality of communications for frontline clinicians and hospitals with a key focus on building solutions that enhance access to high quality patient data.

Feedback has developed a toolkit of clinical communications apps. Its core, regulatory approved product is Bleepa, a revolutionary medical imaging app enabling remote and secure communications between frontline clinicians and teams. CareLocker is an evolutionary GDPR compliant patient-centric cloud architecture - its proprietary technology enables an easy route to creation and mobilisation of individual healthcare records. Bleepa Box is a specialist tool to enable image transfer from remote settings to the Bleepa platform over mobile networks.

The Company has a number of growth opportunities domestically and internationally across a range of markets including the NHS, the veterinary market and private healthcare providers and its highly scalable Software as a Service ("SaaS")-based revenue model is expected to provide increasing levels of visibility as the Company grows its customer base.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOREAFFPALFAEFA

(END) Dow Jones Newswires

January 31, 2022 01:59 ET (06:59 GMT)

Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Feedback Charts.
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Feedback Charts.